|

Famotidine Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Pepcid, Pepcid AC, Pepcid®

Pipeline

Phase 2: 1Phase 4: 1Phase 1/2: 1

Top Sponsors

  • M.D. Anderson Cancer Center2
  • Emory University1

Indications

  • Cancer3
  • Carcinomatosis1
  • Intraperitoneal Paclitaxel1
  • Metastatic Appendiceal Adenocarcinoma1
  • Gastric Adenocarcinoma1

Houston, Texas2 trials

A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

MD Anderson Cancer Center

Phase 1/2
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

M D Anderson Cancer Center

Phase 2

Atlanta, Georgia1 trial

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University Hospital/Winship Cancer Institute

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.